Hospitals beginning their annual 340B recertification process this week will face new federal requirements around drug shipping addresses and entity-owned [...] …
Regulatory
Pharmaceutical giant AbbVie recently urged a federal court to reject HRSA’s attempt to dismiss its lawsuit challenging the agency’s longstanding [...] …
Please Login or Become a Paid Subscriber to View this Content
HRSA’s revised 340B rebate pilot unveiled last Friday appears more likely to withstand a legal challenge than the agency’s first [...] …
Please Login or Become a Paid Subscriber to View this Content
A large California drugmaker recently announced it will soon require all covered entities to submit claims-level data for 340B purchases, [...] …
Please Login or Become a Paid Subscriber to View this Content
340B stakeholders offered competing reactions Friday to HRSA’s new 340B rebate model pilot, with hospital and health center groups condemning [...] …
Please Login or Become a Paid Subscriber to View this Content
HRSA on Friday released a new 340B rebate pilot set to take effect on Jan. 1, 2027, reviving its controversial [...] …
Please Login or Become a Paid Subscriber to View this Content
White House regulators this week completed their review of HRSA’s latest 340B rebate pilot proposal after reclassifying it as “economically [...] …
Please Login or Become a Paid Subscriber to View this Content
The Trump administration on Tuesday announced plans to end subsidies that help lower Medicare drug premiums—a program which it argued [...] …
Please Login or Become a Paid Subscriber to View this Content
The 10th decision under HRSA’s 340B Administrative Dispute Resolution (ADR) once again sided with a drugmaker, marking another loss for [...] …
Please Login or Become a Paid Subscriber to View this Content
White House officials on Wednesday held their last scheduled regulatory meeting on HRSA’s pending 340B rebate pilot guidance, potentially bringing [...] …